The problem has big implications for both private and government insurers as more promising drugs come down the pipeline.
Christopher Snowbeck, Minneapolis Star Tribune
Sat, 04/18/2015 - 3:25pm
The problem has big implications for both private and government insurers as more promising drugs come down the pipeline.